Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 175

1.

Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.

Sousa H, Mesquita L, Ribeiro J, Catarino R, Breda E, Medeiros R.

Immunobiology. 2016 Feb;221(2):145-52. doi: 10.1016/j.imbio.2015.09.015. Epub 2015 Sep 11.

PMID:
26391153
2.

Association of interleukin-10 (IL10) promoter genotypes with nasopharyngeal carcinoma risk in Taiwan.

Tsai CW, Tsai MH, Shih LC, Chang WS, Lin CC, Bau DT.

Anticancer Res. 2013 Aug;33(8):3391-6.

PMID:
23898109
3.

5'UTR +24T>C CR2 is not associated with nasopharyngeal carcinoma development in the North Region of Portugal.

Sousa H, Bastos MJ, Ribeiro J, Oliveira S, Breda E, Catarino R, Medeiros R.

Oral Dis. 2016 May;22(4):280-4. doi: 10.1111/odi.12436. Epub 2016 Feb 23.

PMID:
26748973
4.

Genetic polymorphisms in host innate immune sensor genes and the risk of nasopharyngeal carcinoma in North Africa.

Moumad K, Lascorz J, Bevier M, Khyatti M, Ennaji MM, Benider A, Huhn S, Lu S, Chouchane L, Corbex M, Hemminki K, Försti A.

G3 (Bethesda). 2013 Jun 21;3(6):971-7. doi: 10.1534/g3.112.005371.

5.

Further evidence for the existence of major susceptibility of nasopharyngeal carcinoma in the region near HLA-A locus in Southern Chinese.

Zhao M, Cai H, Li X, Zheng H, Yang X, Fang W, Zhang L, Wei G, Li M, Yao K, Li X.

J Transl Med. 2012 Mar 22;10:57. doi: 10.1186/1479-5876-10-57.

6.

Significant association of Interleukin-10 genotypes and oral cancer susceptibility in Taiwan.

Tsai CW, Chang WS, Lin KC, Shih LC, Tsai MH, Hsiao CL, Yang MD, Lin CC, Bau DT.

Anticancer Res. 2014 Jul;34(7):3731-7.

PMID:
24982395
7.

Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma.

Wei YS, Kuang XH, Zhu YH, Liang WB, Yang ZH, Tai SH, Zhao Y, Zhang L.

Tissue Antigens. 2007 Jul;70(1):12-7.

PMID:
17559576
8.

Functional polymorphism in the 5'-UTR of CR2 is associated with susceptibility to nasopharyngeal carcinoma.

Fan Q, He JF, Wang QR, Cai HB, Sun XG, Zhou XX, Qin HD, Shugart YY, Jia WH.

Oncol Rep. 2013 Jul;30(1):11-6. doi: 10.3892/or.2013.2421. Epub 2013 Apr 23.

9.

Association of IL-1B gene polymorphisms with nasopharyngeal carcinoma in a Chinese population.

Zhu Y, Xu Y, Wei Y, Liang W, Liao M, Zhang L.

Clin Oncol (R Coll Radiol). 2008 Apr;20(3):207-11. doi: 10.1016/j.clon.2008.01.003. Epub 2008 Mar 4.

PMID:
18289837
10.

Genetic risk markers for nasopharyngeal carcinoma in Portugal: tumor necrosis factor alpha  -308G >A polymorphism.

Sousa H, Breda E, Santos AM, Catarino R, Pinto D, Medeiros R.

DNA Cell Biol. 2011 Feb;30(2):99-103. doi: 10.1089/dna.2010.1086. Epub 2010 Sep 28.

PMID:
20874489
11.

A single nucleotide polymorphism in the Epstein-Barr virus genome is strongly associated with a high risk of nasopharyngeal carcinoma.

Feng FT, Cui Q, Liu WS, Guo YM, Feng QS, Chen LZ, Xu M, Luo B, Li DJ, Hu LF, Middeldorp JM, Ramayanti O, Tao Q, Cao SM, Jia WH, Bei JX, Zeng YX.

Chin J Cancer. 2015 Dec 16;34(12):563-72. doi: 10.1186/s40880-015-0073-z.

12.

IL-1RN VNTR polymorphism as a susceptibility marker for nasopharyngeal carcinoma in Portugal.

Sousa H, Breda E, Santos AM, Catarino R, Pinto D, Canedo P, Machado JC, Medeiros R.

Arch Oral Biol. 2013 Aug;58(8):1040-6. doi: 10.1016/j.archoralbio.2013.02.004. Epub 2013 Apr 3.

PMID:
23562526
13.

Association of Single-Nucleotide Polymorphisms in DC-SIGN with Nasopharyngeal Carcinoma Susceptibility.

Li S, Lu Z, Yao M, Ning S, Wu Y, Zhou X, Zhong C, Yan K, Xie Y, Wei Z.

Dis Markers. 2017;2017:6309754. doi: 10.1155/2017/6309754. Epub 2017 Jun 14.

14.

Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma.

Qiu F, Yang L, Zhang L, Yang X, Yang R, Fang W, Wu D, Chen J, Xie C, Huang D, Zhou Y, Lu J.

Gene. 2015 Jul 10;565(2):180-6. doi: 10.1016/j.gene.2015.04.008. Epub 2015 Apr 8.

PMID:
25861865
15.

Relationships between genetic polymorphisms in inflammation-related factor gene and the pathogenesis of nasopharyngeal cancer.

Qu YL, Yu H, Chen YZ, Zhao YX, Chen GJ, Bai L, Liu D, Su HX, Wang HT.

Tumour Biol. 2014 Sep;35(9):9411-8. doi: 10.1007/s13277-014-2123-6. Epub 2014 Jun 22. Retraction in: Qu YL, Yu H, Chen YZ, Zhao YX, Chen GJ, Bai L, Liu D, Su HX, Wang HT. Tumour Biol. 2015 Aug;36(9):7311.

PMID:
24952889
16.

Interleukin-10 and interferon-gamma gene polymorphisms in patients with nasopharyngeal carcinoma.

Farhat K, Hassen E, Gabbouj S, Bouaouina N, Chouchane L.

Int J Immunogenet. 2008 Jun;35(3):197-205. doi: 10.1111/j.1744-313X.2008.00752.x. Epub 2008 Feb 28.

PMID:
18312596
17.

Sequence-based typing of HLA-A gene in 930 patients with nasopharyngeal carcinoma in Hunan province, southern China.

Tian W, Zhu FM, Wang WY, Cai JH, Zhang W, Li LX, Liu KL, Jin HK, Wang F.

Tissue Antigens. 2015 Jul;86(1):15-20. doi: 10.1111/tan.12576. Epub 2015 May 4.

PMID:
25940993
18.

A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.

Liu Y, Cai H, Liu J, Fan H, Wang Z, Wang Q, Shao M, Sun X, Diao J, Liu Y, Shi Y, Fan Q.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):660-5. doi: 10.1016/j.bbrc.2013.02.024. Epub 2013 Feb 14.

PMID:
23416081
19.

Identification of a functional variant in SPLUNC1 associated with nasopharyngeal carcinoma susceptibility among Malaysian Chinese.

Yew PY, Mushiroda T, Kiyotani K, Govindasamy GK, Yap LF, Teo SH, Lim PV, Govindaraju S, Ratnavelu K, Sam CK, Yap YY, Khoo AS, Pua KC, Nakamura Y; Malaysian NPC Study Group, Ng CC.

Mol Carcinog. 2012 Oct;51 Suppl 1:E74-82. doi: 10.1002/mc.21857. Epub 2011 Dec 27.

PMID:
22213098
20.

Supplemental Content

Support Center